ALGOTHERAPEUTIX
17.11.2021 10:04:21 CET | Business Wire | Press release
France-based biotechnology company AlgoTherapeutix, developer of ATX01, an innovative topical treatment for the pain of peripheral neuropathy, announced today that the ATX01 Phase I trial successfully reached its safety and pharmacokinetics objectives, clearing the way for Phase II development in Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Stéphane Thiroloix , Founder & CEO of AlgoTherapeutix, comments : “The outcome of this Phase I trial is an important milestone for AlgoTherapeutix. We are delighted that ATX01’s innovative approach and formulation did not raise any safety concern, and its PK profile is consistent with our objectives. We are now busy preparing for the pivotal Phase II CIPN study.”
Over half of cancer patients treated with chemotherapy - over two million patients in the US and Europe - develop CIPN and experience sensory symptoms and pain in the feet and hands: loss of sensitivity, tingling, burning, cold and intense pain can persist for months to years after treatment. CIPN is a leading cause of modification or interruption of chemotherapy. To this date, no therapeutic approach has offered a satisfactory response for patients and their caregivers, oncologists and pain specialists.
A recent publication in the “Journal of Pain” describes the exploratory pharmacological impact of high-dose topical amitriptyline in CIPN patients along with the mechanism of action supporting its activity (https://doi.org/10.1016/j.jpain.2020.11.002 )
About AlgoTherapeutix : AlgoTherapeutix is a French biotech founded in 2018 to develop innovative solutions for complex pain. In 2020, AlgoTherapeutix raised a 12 M€ Series A led by Bpifrance and Omnes Capital to move its lead program ATX01 into clinical development. ATX01 is Phase II ready in painful peripheral neuropathy.
More information on AlgoTherapeutix : www.algotx.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117005624/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wolters Kluwer Brings Libra AI Workflows into InView Legal for Belgian Legal Professionals17.6.2026 09:00:00 CEST | Press release
Following the integration of InView content in the Libra by Wolters Kluwer legal AI workspace earlier this year, Libra AI functionalities are now also available in InView Legal Belgium via Libra add-in Wolters Kluwer Legal & Regulatory today announced the integration of Libra by Wolters Kluwer AI workflows in InView Legal (formerly known as Jura) in Belgium. This integration brings generative AI features directly into the research workflow of legal professionals and allows a seamless experience without switching between tools. The integration follows the launch of the Libra legal AI workspace in Belgium in February, combining AI with authoritative legal content from InView Legal and supporting lawyers across their full workflow, from research to analysis and document drafting. With the newly launched Libra add-in for InView Legal customers can use Libra’s AI functionalities for drafting, review and analysis in one unified environment, handling their work end-to-end. The solution reflec
Zoya Technologies Launches Clinical AI Terminal Engineered to Operate Without Internet Connectivity17.6.2026 09:00:00 CEST | Press release
ZoyeMed 3.0 Resilience Edition runs the complete Longitudinal Multimodal Model on-device, supporting a full medical episode - triage, examination, 120+ point-of-care tests, and prescription support - in fully disconnected environments Almost every digital health system assumes the internet will be there. Zoya Technologies today launched the ZoyeMed 3.0 Resilience Edition, a clinical AI terminal engineered to deliver a complete medical episode without an internet connection at any stage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617381037/en/ The ZoyeMed 3.0 Resilience Edition - a fully standalone clinical AI terminal engineered to operate without internet connectivity, integrating point-of-care diagnostics, examination tools, and on-device AI in a single 5-square-metre footprint (Photo: AETOSWire) Continuity of care is the first casualty of infrastructure disruption. Disasters, grid instability, and remote deployment
Owl Labs Launches Owl 360 Services, Bringing Enterprise Grade Intelligence to Hybrid Meetings17.6.2026 09:00:00 CEST | Press release
The company's first tiered subscription service delivers differentiated analytics, providing deeper visibility and control across growing device fleets for IT teams globally Owl Labs, the leader in 360-degree AI-powered video conferencing and hybrid collaboration technology, today announced Owl 360 Services, its first subscription service built to meet the needs of IT administrators. As organisations look to support hybrid work with deeper video enablement across more spaces, Owl 360 Services delivers three subscription tiers, offering dedicated support, centralised device management, proactive insights, and warranty coverage scaled to the size and complexity of the deployment. From launch, every Owl Labs device worldwide, whether newly purchased or already owned, is enrolled in the Core tier at no additional cost, giving all customers built-in analytics from the start. The Enhanced tier, available for direct purchase globally from this summer, adds advanced analytics, dashboards, meet
Cognite Launches Novel Integrated Supply Chain Offering to Deliver Unprecedented Business Value with AI17.6.2026 08:00:00 CEST | Press release
AI agents, apps, and data models built on the Cognite AI and Data Platform help operations and supply chain teams increase resiliency, reduce costly decision latency, and protect margins Cognite, a global leader in Industrial AI, today announced the launch of its Integrated Supply Chain offering. This new solution area extends the Cognite AI and Data Platform beyond the plant, equipping industrial teams with real-time visibility, insights, and cross-functional context to finally bridge the long-standing data gap between production and supply chain operations. Unifying these siloed teams empowers organizations to respond faster and smarter to internal or external disruptions, execute adaptive pivots, and better protect margins. The divide between production and supply chain operations has increased over time, as competing KPIs, organizational initiatives, and specialized software further fragment decision-making processes. As a result, any operational disruption can force costly, reacti
Tigo Energy Delivers New GO Optimized Energy Storage System to European Residential Market17.6.2026 06:00:00 CEST | Press release
Tigo to celebrate installer customers and highlight expanded residential energy technology ecosystem at Intersolar 2026, as GO Battery shipments begin in Europe. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the GO Battery, as part of the GO Optimized ESS, is now shipping for European market customers, fulfilling the preorder commitments made when the product was introduced in April 2026. The Company will showcase live system demonstrations of the GO Optimized ESS at Intersolar Europe 2026, taking place June 23–25 at Messe München in Munich, Germany, at booth B3.140. Weiss-Blau GmbH, a member of the Tigo Installer Loyalty Program, will join Tigo at the show as one of the first installation companies to deploy the system in the European residential market. The GO Battery's modular architecture, built on 3.68kWh units configurable from 7.3kWh to 47.9kWh, is designed to give installers flexible si
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom